메뉴 건너뛰기




Volumn 22, Issue 8, 2010, Pages 905-911

The role of carvedilol in the management of portal hypertension

Author keywords

beta blockers; cirrhosis; hepatic venous pressure gradient; portal hypertension

Indexed keywords

CARVEDILOL; NEBIVOLOL; PROPRANOLOL; ANTIHYPERTENSIVE AGENT; BENZOPYRAN DERIVATIVE; CARBAZOLE DERIVATIVE; ETHANOLAMINE DERIVATIVE; NITRIC ACID DERIVATIVE; PROPANOLAMINE DERIVATIVE;

EID: 77955208253     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283367a99     Document Type: Review
Times cited : (40)

References (38)
  • 1
    • 0030728035 scopus 로고    scopus 로고
    • Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding
    • Damico G, Luca A. Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol 1997; 11:243-256.
    • (1997) Baillieres Clin Gastroenterol , vol.11 , pp. 243-256
    • Damico, G.1    Luca, A.2
  • 2
    • 0025016059 scopus 로고
    • Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
    • Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990; 99:1401-1407.
    • (1990) Gastroenterology , vol.99 , pp. 1401-1407
    • Groszmann, R.J.1    Bosch, J.2    Grace, N.D.3    Conn, H.O.4    Garcia-Tsao, G.5    Navasa, M.6
  • 3
    • 0028790232 scopus 로고
    • Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis
    • Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346:1056-1059.
    • (1995) Lancet , vol.346 , pp. 1056-1059
    • Feu, F.1    Garcia-Pagan, J.C.2    Bosch, J.3    Luca, A.4    Teres, J.5    Escorsell, A.6
  • 5
    • 0020449643 scopus 로고
    • The effect of propranolol on portal hypertension in patients with cirrhosis: A hemodynamic study
    • Lebrec D, Hillon P, Munoz C, Goldfarb G, Nouel O, Benhamou JP. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982; 2:523-527. (Pubitemid 13173931)
    • (1982) Hepatology , vol.2 , Issue.5 , pp. 523-527
    • Lebrec, D.1    Hillon, P.2    Munoz, C.3
  • 6
    • 0021927396 scopus 로고
    • Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model
    • Kroeger RJ, Groszmann RJ. Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model. Hepatology 1985; 5:97-101.
    • (1985) Hepatology , vol.5 , pp. 97-101
    • Kroeger, R.J.1    Groszmann, R.J.2
  • 7
    • 0036731212 scopus 로고    scopus 로고
    • Primary prophylaxis of variceal hemorrhage: A randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate
    • Lui HF, Stanley AJ, Forrest EH, Jalan R, Hislop WS, Mills PR, et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002; 123:735-744.
    • (2002) Gastroenterology , vol.123 , pp. 735-744
    • Lui, H.F.1    Stanley, A.J.2    Forrest, E.H.3    Jalan, R.4    Hislop, W.S.5    Mills, P.R.6
  • 8
    • 34548669602 scopus 로고    scopus 로고
    • Variceal band ligation versus beta-blockers for primary prevention of variceal bleeding: A meta-analysis
    • Tripathi D, Graham C, Hayes PC. Variceal band ligation versus beta-blockers for primary prevention of variceal bleeding: a meta-analysis. Eur J Gastroenterol Hepatol 2007; 19:835-845.
    • (2007) Eur J Gastroenterol Hepatol , vol.19 , pp. 835-845
    • Tripathi, D.1    Graham, C.2    Hayes, P.C.3
  • 9
    • 0025319863 scopus 로고
    • Enhancement of portal pressure reduction by the association of isosorbide- 5-mononitrate to propranolol administration in patients with cirrhosis
    • Garcia-Pagan JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodes J. Enhancement of portal pressure reduction by the association of isosorbide- 5-mononitrate to propranolol administration in patients with cirrhosis. Hepatology 1990; 11:230-238.
    • (1990) Hepatology , vol.11 , pp. 230-238
    • Garcia-Pagan, J.C.1    Navasa, M.2    Bosch, J.3    Bru, C.4    Pizcueta, P.5    Rodes, J.6
  • 10
    • 0030995729 scopus 로고    scopus 로고
    • Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone
    • Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G, et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Hepatology 1997; 26:34-39.
    • (1997) Hepatology , vol.26 , pp. 34-39
    • Merkel, C.1    Sacerdoti, D.2    Bolognesi, M.3    Enzo, E.4    Marin, R.5    Bombonato, G.6
  • 12
    • 7044237420 scopus 로고    scopus 로고
    • Acute administration of carvedilol is more effective than propranolol plus isosorbide-5- mononitrate in the reduction of portal pressure in patients with viral cirrhosis
    • Lin HC, Yang YY, Hou MC, Huang YT, Lee FY, Lee SD. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5- mononitrate in the reduction of portal pressure in patients with viral cirrhosis. Am J Gastroenterol 2004; 99:1953-1958.
    • (2004) Am J Gastroenterol , vol.99 , pp. 1953-1958
    • Lin, H.C.1    Yang, Y.Y.2    Hou, M.C.3    Huang, Y.T.4    Lee, F.Y.5    Lee, S.D.6
  • 13
    • 0036894514 scopus 로고    scopus 로고
    • Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis
    • Banares R, Moitinho E, Matilla A, Garcia-Pagan JC, Lampreave JL, Piera C, et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology 2002; 36:1367-1373.
    • (2002) Hepatology , vol.36 , pp. 1367-1373
    • Banares, R.1    Moitinho, E.2    Matilla, A.3    Garcia-Pagan, J.C.4    Lampreave, J.L.5    Piera, C.6
  • 14
    • 0036227250 scopus 로고    scopus 로고
    • Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics
    • De BK, Das D, Sen S, Biswas PK, Mandal SK, Majumdar D, et al. Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics. J Gastroenterol Hepatol 2002; 17:183-189.
    • (2002) J Gastroenterol Hepatol , vol.17 , pp. 183-189
    • De Bk Das, D.1    Sen, S.2    Biswas, P.K.3    Mandal, S.K.4    Majumdar, D.5
  • 15
    • 0036185720 scopus 로고    scopus 로고
    • Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension
    • Tripathi D, Therapondos G, Lui HF, Stanley AJ, Hayes PC. Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther 2002; 16:373-380.
    • (2002) Aliment Pharmacol Ther , vol.16 , pp. 373-380
    • Tripathi, D.1    Therapondos, G.2    Lui, H.F.3    Stanley, A.J.4    Hayes, P.C.5
  • 16
    • 0033000308 scopus 로고    scopus 로고
    • Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1- adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis
    • Banares R, Moitinho E, Piqueras B, Casado M, Garcia-Pagan JC, De Diego A, et al. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1- adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology 1999; 30:79-83.
    • (1999) Hepatology , vol.30 , pp. 79-83
    • Banares, R.1    Moitinho, E.2    Piqueras, B.3    Casado, M.4    Garcia-Pagan, J.C.5    De Diego, A.6
  • 17
    • 0033040460 scopus 로고    scopus 로고
    • Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis
    • Stanley AJ, Therapondos G, Helmy A, Hayes PC. Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis. J Hepatol 1999; 30:479-484.
    • (1999) J Hepatol , vol.30 , pp. 479-484
    • Stanley, A.J.1    Therapondos, G.2    Helmy, A.3    Hayes, P.C.4
  • 18
    • 0030977409 scopus 로고    scopus 로고
    • Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension
    • Sekiyama T, Komeichi H, Nagano T, Ohsuga M, Terada H, Katsuta Y, et al. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension. Arzneimittelforschung 1997; 47:353-355.
    • (1997) Arzneimittelforschung , vol.47 , pp. 353-355
    • Sekiyama, T.1    Komeichi, H.2    Nagano, T.3    Ohsuga, M.4    Terada, H.5    Katsuta, Y.6
  • 19
    • 0030446623 scopus 로고    scopus 로고
    • Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis
    • Forrest EH, Bouchier IA, Hayes PC. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis. J Hepatol 1996; 25:909-915.
    • (1996) J Hepatol , vol.25 , pp. 909-915
    • Forrest, E.H.1    Bouchier, I.A.2    Hayes, P.C.3
  • 20
    • 84925563679 scopus 로고    scopus 로고
    • Acute and 14-days hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosis. A pilot study
    • Silkauskaite V, Pranculis A, Kupcinskas J, Petrenkiene V, Kupcinskas L. Acute and 14-days hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosis. A pilot study. J Hepatol 2009; 50:226.
    • (2009) J Hepatol , vol.50 , pp. 226
    • Silkauskaite, V.1    Pranculis, A.2    Kupcinskas, J.3    Petrenkiene, V.4    Kupcinskas, L.5
  • 21
    • 70349254117 scopus 로고    scopus 로고
    • Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed
    • Tripathi D, Ferguson JW, Kochar N, Leithead JA, Therapondos G, McAvoy NC, et al. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology 2009; 50:825-833.
    • (2009) Hepatology , vol.50 , pp. 825-833
    • Tripathi, D.1    Ferguson, J.W.2    Kochar, N.3    Leithead, J.A.4    Therapondos, G.5    McAvoy, N.C.6
  • 23
    • 0033681003 scopus 로고    scopus 로고
    • Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress
    • Abreu RM, Santos DJ, Moreno AJ. Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress. J Pharmacol Exp Ther 2000; 295:1022-1030.
    • (2000) J Pharmacol Exp Ther , vol.295 , pp. 1022-1030
    • Abreu, R.M.1    Santos, D.J.2    Moreno, A.J.3
  • 25
    • 0037347309 scopus 로고    scopus 로고
    • Chenodeoxycholate induction of mitochondrial permeability transition pore is associated with increased membrane fluidity and cytochrome c release: Protective role of carvedilol
    • Rolo AP, Oliveira PJ, Moreno AJ, Palmeira CM. Chenodeoxycholate induction of mitochondrial permeability transition pore is associated with increased membrane fluidity and cytochrome c release: protective role of carvedilol. Mitochondrion 2003; 2:305-311.
    • (2003) Mitochondrion , vol.2 , pp. 305-311
    • Rolo, A.P.1    Oliveira, P.J.2    Moreno, A.J.3    Palmeira, C.M.4
  • 26
    • 7744237066 scopus 로고    scopus 로고
    • Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial
    • Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 2004; 292:2227-2236.
    • (2004) JAMA , vol.292 , pp. 2227-2236
    • Bakris, G.L.1    Fonseca, V.2    Katholi, R.E.3    McGill, J.B.4    Messerli, F.H.5    Phillips, R.A.6
  • 27
    • 0032506784 scopus 로고    scopus 로고
    • Carvedilol
    • Frishman WH. Carvedilol. N Engl J Med 1998; 339:1759-1765.
    • (1998) N Engl J Med , vol.339 , pp. 1759-1765
    • Frishman, W.H.1
  • 28
    • 0028271342 scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of carvedilol
    • Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet 1994; 26:335-346.
    • (1994) Clin Pharmacokinet , vol.26 , pp. 335-346
    • Morgan, T.1
  • 29
    • 0025300364 scopus 로고
    • Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound
    • Neugebauer G, Akpan W, Kaufmann B, Reiff K. Stereoselective disposition ofcarvedilol in man after intravenous and oral administration of the racemic compound. Eur J Clin Pharmacol 1990; 38 (Suppl 2):S108-S111.
    • (1990) Eur J Clin Pharmacol , vol.38 , Issue.SUPPL. 2
    • Neugebauer, G.1    Akpan, W.2    Kaufmann, B.3    Reiff, K.4
  • 30
    • 0026689811 scopus 로고
    • Disposition of carvedilol enantiomers in patients with liver cirrhosis: Evidence for disappearance of stereoselective first-pass extraction
    • Neugebauer G, Gabor M, Reiff K. Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective first-pass extraction. J Cardiovasc Pharmacol 1992; 19 (Suppl 1): S142-S146.
    • (1992) J Cardiovasc Pharmacol , vol.19 , Issue.SUPPL. 1
    • Neugebauer, G.1    Gabor, M.2    Reiff, K.3
  • 32
    • 0021948418 scopus 로고
    • Effects of propranolol on portal hemodynamics in patients with chronic liver disease
    • Ohnishi K, Nakayama T, Saito M, Hatano H, Tsukamoto T, Terabayashi H, et al. Effects of propranolol on portal hemodynamics in patients with chronic liver disease. Am J Gastroenterol 1985; 80:132-135. (Pubitemid 15137209)
    • (1985) American Journal of Gastroenterology , vol.80 , Issue.2 , pp. 132-135
    • Ohnishi, K.1    Nakayama, T.2    Saito, M.3
  • 33
    • 0023131157 scopus 로고
    • Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis
    • Mastai R, Bosch J, Navasa M, Kravetz D, Bruix J, Viola C, et al. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis. J Hepatol 1987; 4:71-79.
    • (1987) J Hepatol , vol.4 , pp. 71-79
    • Mastai, R.1    Bosch, J.2    Navasa, M.3    Kravetz, D.4    Bruix, J.5    Viola, C.6
  • 34
    • 0027978527 scopus 로고
    • Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension
    • Albillos A, Lledo JL, Banares R, Rossi I, Iborra J, Calleja JL, et al. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension. Hepatology 1994; 20:611-617.
    • (1994) Hepatology , vol.20 , pp. 611-617
    • Albillos, A.1    Lledo, J.L.2    Banares, R.3    Rossi, I.4    Iborra, J.5    Calleja, J.L.6
  • 35
    • 0036284634 scopus 로고    scopus 로고
    • Hepatic stellate cells: Role in microcirculation and pathophysiology of portal hypertension
    • Reynaert H, Thompson MG, Thomas T, Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 2002; 50:571-581.
    • (2002) Gut , vol.50 , pp. 571-581
    • Reynaert, H.1    Thompson, M.G.2    Thomas, T.3    Geerts, A.4
  • 36
    • 33744813832 scopus 로고    scopus 로고
    • Hemodynamic effects of one week of carvedilol administration on cirrhotic rats
    • Lin HC, Huang YT, Wei HC, Yang YY, Lee TY, Wang YW, et al. Hemodynamic effects of one week of carvedilol administration on cirrhotic rats. J Gastroenterol 2006; 41:361-368.
    • (2006) J Gastroenterol , vol.41 , pp. 361-368
    • Lin, H.C.1    Huang, Y.T.2    Wei, H.C.3    Yang, Y.Y.4    Lee, T.Y.5    Wang, Y.W.6
  • 37
    • 0026630083 scopus 로고
    • Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension
    • Koshy A, Sekiyama T, Hadengue A, Cerini R, Braillon A, Lebrec D. Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension. J Gastroenterol Hepatol 1992; 7:449-454.
    • (1992) J Gastroenterol Hepatol , vol.7 , pp. 449-454
    • Koshy, A.1    Sekiyama, T.2    Hadengue, A.3    Cerini, R.4    Braillon, A.5    Lebrec, D.6
  • 38
    • 1242291938 scopus 로고    scopus 로고
    • The hepatic venous pressure gradient: Anything worth doing should be done right
    • Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004; 39:280-282.
    • (2004) Hepatology , vol.39 , pp. 280-282
    • Groszmann, R.J.1    Wongcharatrawee, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.